# Page 70 Audit — Rec 3.1.2 Rationale (Cont.), PP 3.1.3 (Shared Decision-Making), PP 3.1.4 (Nutrition Providers)

| Field | Value |
|-------|-------|
| **Page** | 70 (PDF page S69) |
| **Content Type** | Rec 3.1.2 rationale continued (Global Burden of Disease: 3M deaths from high sodium, NAS Dietary Reference Intakes sodium/potassium, DASH Sodium Trial: 1525 mg/day balance, 1500 mg/day recommendation, sodium <2g vs 1.5g vs 2.3g reconciliation), PP 3.1.3 (shared decision-making in nutrition management, patient-centered care, behavior change takes 2-8 months), PP 3.1.4 (accredited nutrition providers, registered dietitians, community health workers, peer counselors, telehealth, mobile apps) |
| **Extracted Spans** | 29 total (2 T1, 27 T2) |
| **Channels** | C, E, F |
| **Disagreements** | 0 |
| **Review Status** | PENDING: 29 |
| **Risk** | Clean |
| **Cross-Check** | Count verified against pipeline DB |
| **Audit Date** | 2026-02-25 |

---

## Source PDF Content

**Rec 3.1.2 Rationale (Continued from p69):**
- Global Burden of Disease Study (2010): high sodium → 3 million deaths + 70 million disability-adjusted life-years; low fruit intake → 2 million deaths + 65 million DALYs
- Risks consistent regardless of socioeconomic level of nations
- With declining kidney function, volume overload common → recommendation applies to ALL CKD severities
- **US NAS Dietary Reference Intakes for Sodium and Potassium**: at least moderate evidence for causal and intake-response relationships
- Neutral balance study with heat stress at **1525 mg/day**
- DASH Sodium Trial + 8 other RCTs → **1500 mg/day for all age groups ≥14**
- For those with intake above **2300 mg**: recommendation is to decrease
- Larger BP reduction effects in hypertensive patients, but benefits applicable to both normotensive and hypertensive
- Work Group reconciliation: sodium <**2 g/d** (above 1.5 g/d, less than 2.3 g/d, much less than average intake of 4-5 g/d)
- **Average global sodium intake: 4-5 g/day** (double the recommendation)

**Practice Point 3.1.3:**
- "Shared decision-making should be a cornerstone of patient-centered nutrition management in patients with diabetes and CKD"
- Modifying dietary intake = long and complex process
- Patients often have multiple chronic comorbidities → conflicting nutrition requirements
- Patient-centered care models → increased adherence + quality of life
- Patient problem-solving: patients select strategies, support self-efficacy
- **Behavior change takes 2-8 months**; patients will fail many times before succeeding
- Family/caregiver involvement highly desirable
- Collaborative care with all providers including primary care

**Practice Point 3.1.4:**
- "Accredited nutrition providers, registered dietitians and diabetes educators, community health workers, peer counselors, or other health workers should be engaged in multidisciplinary nutrition care"
- Physicians often lack time and expertise for detailed dietary modification
- Complex reporting by patient + nutritional analysis by provider + proposed options
- Referral to: diabetes educator, registered dietitian nutritionist, international nutrition-credentialed professional, community health nurse
- Where accredited providers scarce: increase peer coaches, community healthcare workers
- Decreased health literacy → more education time needed
- Technology: mobile nutrition apps, social media, nutrient databases, telehealth
- "Technology can be used to enhance the patient's ability to learn and utilize information"

---

## Key Spans Assessment

### Tier 1 Spans (2)

| Span | Channel | Conf | Assessment |
|------|---------|------|------------|
| "Practice Point 3.1.4" (C) | C | 98% | **→ T3** — PP label only; the actual PP 3.1.4 text about nutrition providers/dietitians NOT captured |
| "Practice Point 3.1.3" (C) | C | 98% | **→ T3** — PP label only; the actual PP 3.1.3 text about shared decision-making NOT captured |

**Summary: 0/2 T1 spans are genuine. Both are PP labels without clinical content — the most persistent pattern in this audit.**

### Tier 2 Spans (27)

| Category | Count | Assessment |
|----------|-------|------------|
| **"sodium"** (C) ×11 | 11 | **ALL → T3** — Electrolyte name repetition (sodium noise explosion continues: p67=10, p68=9, p70=11 = 30 total in sodium section) |
| **"Sodium"** (C) ×3 | 3 | **ALL → T3** — Capitalized variant of sodium noise |
| **"potassium"** (C) | 1 | **→ T3** — Electrolyte name without context |
| **"Potassium"** (C) | 1 | **→ T3** — Capitalized variant |
| **"avoid"** (E) ×2 | 2 | **ALL → T3** — Action verb without context (GLiNER false positive) |
| **"2 g"** (C) ×2 | 2 | **✅ T2 OK** — Sodium threshold fragments (2g/d recommendation), though already captured extensively on p67 |
| **"1525 mg/day"** (C) | 1 | **⚠️ SHOULD BE T1** — Neutral balance study sodium threshold (NAS Dietary Reference Intakes); unique dosing value |
| **"1500 mg/day"** (C) | 1 | **⚠️ SHOULD BE T1** — NAS/DASH recommendation: 1500 mg/day for all age groups ≥14; specific dosing threshold |
| **"2300 mg"** (C) | 1 | **⚠️ SHOULD BE T1** — Upper sodium threshold: "For those with intakes above 2300 mg, recommendation is to decrease" |
| **"1.5 g"** (C) | 1 | **✅ T2 OK** — Lower sodium bound in Work Group reconciliation (1.5-2.3 g range) |
| **"2.3 g"** (C) | 1 | **✅ T2 OK** — Upper sodium bound in Work Group reconciliation |
| **"5 g"** (C) | 1 | **→ T3** — From "5 g of sodium chloride" (salt conversion, already captured on p67) |
| **"Application of patient-centered care models has shown increased adherence and increased quality of life for participants..."** (F) | 1 | **✅ T2 CORRECT** — Evidence for patient-centered care; meaningful F channel extraction |
| **"technology can be used to enhance the patient's ability to learn and utilize information."** (F) | 1 | **✅ T2 OK** — Technology/telehealth recommendation from PP 3.1.4; borderline T3 (general process guidance) |

**Summary: 6/27 T2 correctly tiered or meaningful (2g ×2, 1.5g, 2.3g thresholds + 2 F sentences). 3 T2 should be T1 (1525 mg/day, 1500 mg/day, 2300 mg — unique NAS thresholds). 18/27 are noise (sodium ×14, potassium ×2, avoid ×2).**

---

## Critical Findings

### ✅ NAS Sodium Thresholds Captured — 3 Unique Values

The C channel captures three clinically significant sodium thresholds from the NAS Dietary Reference Intakes discussion:
1. **1525 mg/day** — neutral balance study with heat stress (minimum physiologic need)
2. **1500 mg/day** — NAS recommendation for all age groups ≥14 (DASH Sodium Trial)
3. **2300 mg** — upper limit: "decrease intake" threshold

These are distinct from the Rec 3.1.2 "2g/day" threshold and represent the NAS evidence base that supports the KDIGO recommendation. All three should be T1.

### ✅ Work Group Reconciliation Thresholds Captured

The C channel also captures "1.5 g" and "2.3 g" from the Work Group's explicit reconciliation statement: "sodium intake should be restricted to <2 g/d, which although above 1.5 g/d, is less than 2.3 g/d." This 3-threshold range (1.5–2.0–2.3 g) is useful for understanding the recommendation's position.

### ❌ Sodium ×14 — WORST PAGE FOR SODIUM NOISE

This page has **14 sodium/Sodium spans** (11 + 3 capitalized), making it the worst page for sodium noise in the entire audit. Combined with pages 67-69:

| Page | Sodium Spans | Total Spans | Sodium % |
|------|-------------|-------------|----------|
| 67 | 10 | 33 | 30% |
| 68 | 9 | 19 | 47% |
| 69 | 0 | 3 | 0% |
| 70 | 14 | 29 | 48% |
| **Total** | **33** | **84** | **39%** |

**33 "sodium" noise spans across 4 pages** — this is even worse than the HbA1c explosion in Chapter 2 on a per-page basis.

### ❌ PP 3.1.3 and PP 3.1.4 Text NOT EXTRACTED

Both Practice Points have their **labels** captured as T1 but their **actual clinical text** is missing:
- PP 3.1.3: "Shared decision-making should be a cornerstone of patient-centered nutrition management..." — NOT captured
- PP 3.1.4: "Accredited nutrition providers, registered dietitians and diabetes educators..." — NOT captured

This continues the persistent pattern where the C channel's regex matches PP/Rec numbering patterns but the surrounding text is not extracted.

### ❌ Missing Critical Content

| Missing Content | Tier | Clinical Importance |
|-----------------|------|---------------------|
| PP 3.1.3 full text: shared decision-making as cornerstone of nutrition management | **T2** | Care process guidance |
| PP 3.1.4 full text: multidisciplinary nutrition team engagement | **T2** | Implementation/referral guidance |
| "Behavior change takes 2-8 months" with repeated failures expected | **T2** | Patient counseling expectation-setting |
| Average global sodium intake 4-5 g/day (double the recommendation) | **T2** | Context for recommendation urgency |
| "Volume overload common with declining kidney function" → sodium restriction applies to ALL CKD | **T2** | Population scope justification |
| NAS "moderate evidence for causal and intake-response relationships" (sodium ↔ BP/CVD) | **T2** | Evidence quality statement |
| Patient self-efficacy and behavioral goal setting model | **T3** | Care delivery model |
| Telehealth/mobile apps for nutrition education in underserved areas | **T3** | Implementation guidance |

---

## Reviewer Recommendation

| Action | Details |
|--------|---------|
| **Decision** | **Conditional ACCEPT** — NAS sodium thresholds (1525/1500/2300 mg) are genuinely useful captures; but sodium ×14 noise dominates; PP 3.1.3/3.1.4 labels without text continue pattern |
| **Tier corrections** | PP labels ×2: T1 → T3; 1525 mg/day: T2 → T1; 1500 mg/day: T2 → T1; 2300 mg: T2 → T1; sodium ×14: T2 → T3; potassium ×2: T2 → T3; avoid ×2: T2 → T3; "5 g": T2 → T3 |
| **Missing T1** | None on this page (NAS thresholds captured as T2, should be elevated) |
| **Missing T2** | PP 3.1.3/3.1.4 text, behavior change 2-8 months, average intake 4-5 g/d, ALL CKD scope |

---

## Completeness Score

| Metric | Value |
|--------|-------|
| **Extraction completeness** | ~30% — 5 sodium thresholds (1525/1500/2300 mg, 1.5g, 2.3g) + 2 F sentences capture key numeric data; PP text and behavioral guidance missing |
| **Tier accuracy** | ~21% (0/2 T1 correct + 6/27 T2 correct = 6/29) |
| **Noise ratio** | ~62% — sodium ×14, potassium ×2, avoid ×2 = 18/29 |
| **Genuine T1 content** | 0 extracted (3 T2 thresholds should be T1) |
| **Prior review** | 0/29 reviewed |
| **Overall quality** | **MODERATE-POOR** — NAS threshold captures valuable but drowned in 14 sodium noise spans; PP text missing |

---

## Post-Review State (2026-02-27, reviewer: claude-auditor)

### Actions Taken

| Action | Count | Details |
|--------|-------|---------|
| **REJECTED** | 20 | sodium x11 (out_of_scope), Sodium x3 (out_of_scope), potassium x1 (out_of_scope), Potassium x1 (out_of_scope), avoid x2 (out_of_scope), "5 g" x1 (duplicate — salt conversion, already on p67), "Practice Point 3.1.3" label (out_of_scope), "Practice Point 3.1.4" label (out_of_scope) |
| **CONFIRMED** | 9 | "2 g" x2 (Rec 3.1.2 sodium threshold), "1525 mg/day" (NAS neutral balance — should be T1), "1500 mg/day" (NAS/DASH recommendation — should be T1), "2300 mg" (upper sodium threshold — should be T1), "1.5 g" (Work Group lower bound), "2.3 g" (Work Group upper bound), patient-centered care evidence sentence (F), technology/telehealth sentence (F) |
| **ADDED** | 5 | See below |

### Spans Added

| # | Text | Span ID | Note |
|---|------|---------|------|
| 1 | "Shared decision-making should be a cornerstone of patient-centered nutrition management in patients with diabetes and CKD." | da637ab1 | PP 3.1.3 full text — only label was extracted |
| 2 | "Accredited nutrition providers, registered dietitians and diabetes educators, community health workers, peer counselors, or other health workers should be engaged in multidisciplinary nutrition care." | e696fd88 | PP 3.1.4 full text — only label was extracted |
| 3 | "Behavior change takes 2-8 months, and patients will fail many times before succeeding." | bda21e62 | Patient counseling expectation-setting from PP 3.1.3 rationale |
| 4 | "Average global sodium intake is 4-5 g/day, which is roughly double the recommendation." | df5ea608 | Contextualizes urgency of Rec 3.1.2 sodium restriction |
| 5 | "With declining kidney function, volume overload is common, and the recommendation to restrict sodium applies to all severities of CKD." | 67d9eaf4 | Population scope — sodium restriction applies to ALL CKD stages |

### Final Span Disposition (Page 70)

| Status | Count | Percentage |
|--------|-------|------------|
| REJECTED | 20 | 59% of original 29+5=34 |
| CONFIRMED | 9 | 26% of original 29+5=34 |
| ADDED | 5 | 15% of original 29+5=34 |
| PENDING | 0 | 0% |
| **Total post-review** | **34** | **14 active (9 confirmed + 5 added)** |

### Quality Improvement

| Metric | Pre-Review | Post-Review |
|--------|-----------|-------------|
| Active clinical spans | ~9 genuine out of 29 | 14 (9 confirmed + 5 added) |
| Noise ratio | 62% (18/29) | 0% (all noise rejected) |
| PP text coverage | 0/2 PPs captured | 2/2 PPs captured (PP 3.1.3, PP 3.1.4) |
| Behavioral guidance | Missing | Added (2-8 months behavior change) |
| Population scope | Missing | Added (ALL CKD severities) |
| Epidemiologic context | Missing | Added (global intake 4-5 g/d) |
| NAS thresholds | 3 captured as T2 | 3 confirmed (noted should be T1) |

---

## Chapter 3 Complete Section Summary (Pages 64-70)

| Page | Content | Spans | Genuine | Noise % | Quality |
|------|---------|-------|---------|---------|---------|
| 64 | Ch3 opening, PP 3.1.1, Rec 3.1.1 (protein) | 10 | ~3 | 50% | **MOD-POOR** |
| 65 | Rec 3.1.1 evidence, Cochrane, Figure 15 | 13 | ~10 | 15% | **GOOD** |
| 66 | Rec 3.1.1 values, Figure 16 (protein table) | 23 | ~5 | 70% | **POOR (FLAG)** |
| 67 | PP 3.1.2, Rec 3.1.2 (sodium), Figure 17 | 33 | ~6 | 67% | **MODERATE** |
| 68 | Rec 3.1.2 evidence, Figure 18 | 19 | ~5 | 68% | **MOD-POOR** |
| 69 | Rec 3.1.2 implementation, Figure 19 | 3 | 0 | 100% | **VERY POOR (FLAG)** |
| 70 | Rec 3.1.2 rationale, PP 3.1.3, PP 3.1.4 | 29 | ~9 | 62% | **MOD-POOR** |
| **Total** | | **130** | **~38** | **~60%** | |

**Chapter 3 Key Patterns:**
1. **Best page**: p65 (evidence prose → F channel fires strongly, 15% noise)
2. **Worst page**: p69 (implementation/figure content → 3 spans, 100% noise)
3. **Sodium noise**: 33 "sodium" spans across pp67-70 (39% of all spans in that range)
4. **PP text missing**: PP 3.1.1 (p64), PP 3.1.2 (p67), PP 3.1.3 (p70), PP 3.1.4 (p70) — all 4 PPs have labels only
5. **Rec text missing**: Rec 3.1.1 (p64), Rec 3.1.2 (p67) — both have fragments only
6. **Figures poorly served**: Figure 15 title only, Figure 16 context-free numbers, Figure 17 not captured, Figure 18 not captured, Figure 19 not captured
7. **F channel effective on evidence prose** but silent on implementation/values content
8. **B channel fired once** (p67 triple-channel, p69 standalone "diuretics") — Chapter 3 has minimal drug content

---

## Raw PDF Gap Analysis (Cross-Check 2026-02-27)

| # | Gap Text (Exact PDF) | Priority | Rationale |
|---|---------------------|----------|-----------|
| 1 | "The US National Academy of Sciences, Engineering, and Medicine recently released Dietary Reference Intakes for Sodium and Potassium, which indicates at least moderate strength of evidence for both causal and intake-response relationships." | **MODERATE** | NAS DRI evidence quality — moderate evidence for sodium-BP/CVD causal and intake-response relationships. KB-1. |
| 2 | "The sodium recommendations were congruent and appropriate to recommend 1500 mg/day for all age groups 14 and over. For those with intakes above 2300 mg, the recommendation is to decrease intake." | **MODERATE** | NAS/DASH sodium recommendation scope — 1500 mg/d for ages ≥14; decrease if above 2300 mg. Contextualizes threshold values. KB-1. |
| 3 | "Larger effects in blood pressure reduction were seen in people with hypertension, but the benefits of sodium reduction were deemed to be applicable to both normotensive and hypertensive people." | **MODERATE** | Sodium restriction benefits BOTH normotensive and hypertensive patients — universality of the recommendation. KB-1. |
| 4 | "In agreement with the WHO, the Work Group judged that sodium intake should be restricted to <2 g/d, which although above 1.5 g/d, is less than 2.3 g/d and much less than the average intake (4-5 g/d)." | **MODERATE** | Work Group reconciliation — explains why <2g/d was chosen: above physiologic minimum (1.5g), below upper limit (2.3g), well below average (4-5g). KB-1. |
| 5 | "A low intake of fruits caused 2 million deaths and 65 million disability-adjusted life-years." | **MODERATE** | Comparative dietary risk — low fruit intake deaths/DALYs from Global Burden of Disease. KB-1. |
| 6 | "This analysis noted that those risks held true regardless of the socioeconomic level of most nations, suggesting that benefits are likely not to vary based on the geographic location." | **MODERATE** | Universality of sodium restriction benefits — holds regardless of socioeconomic level or geographic location. KB-1. |
| 7 | "Patients with diabetes and CKD often have other chronic comorbidities. Nutrition therapies may need to be coordinated to allow for patient-centered solutions, including recognition of differences in individuals such as age, dentition, cultural food preferences, finances, and patient goals, and to help align their often-conflicting comorbid nutrition requirements." | **MODERATE** | Comorbidity coordination — conflicting nutrition requirements; patient-centered factors (age, dentition, culture, finances). KB-1. |
| 8 | "Involvement and education of the patients' families and/or caregivers are also highly desirable. Care must be collaborative, involving all providers, including the primary care provider, and allow for informed decision-making by patients and often their families." | **MODERATE** | Family/caregiver involvement and collaborative care mandate across all providers. KB-1. |
| 9 | "It is quite possible that the physician in these situations has neither the time, nor the expertise, to help with detailed repeated modification of the patient's diet. Referral to a diabetes educator, registered dietician nutritionist, international nutrition-credentialed professional, or community health nurse would be desirable." | **MODERATE** | Physician referral justification and referral pathway to nutrition specialists. KB-1. |
| 10 | "In areas where accredited nutrition providers are scarce or nonexistent, effort should be placed on increasing the number of cost-effective peer coaches or community healthcare workers to help educate and support patients who need ongoing care coordination and culturally appropriate care. Patients who have decreased health literacy will require more time spent in an education session with healthcare providers." | **MODERATE** | Resource-limited settings: peer coaches and community workers; health literacy accommodation. KB-1. |

**All 10 gaps added via API (all 201).**

---

## Post-Review State (Final — with gap fills)

| Metric | Value |
|--------|-------|
| **Total spans (post-review)** | 44 (29 original + 5 agent-added + 10 gap-fill) |
| **Reviewed** | 44/44 (100%) |
| **CONFIRMED** | 9 |
| **REJECTED** | 20 |
| **ADDED (agent)** | 5 |
| **ADDED (gap fill)** | 10 |
| **Total ADDED** | 15 |
| **Pipeline 2 ready** | 24 (9 confirmed + 15 added) |
| **Completeness (post-review)** | ~92% — NAS DRI evidence quality (moderate strength causal/intake-response); NAS 1500 mg/d for ages ≥14 + 2300 mg decrease threshold; benefits for normotensive AND hypertensive; Work Group reconciliation (1.5/2.0/2.3 g/d logic); GBD low fruit intake (2M deaths/65M DALYs); socioeconomic universality; sodium thresholds (1525/1500/2300 mg, 1.5/2.0/2.3 g); PP 3.1.3 shared decision-making; PP 3.1.4 nutrition providers; behavior change 2-8 months; average intake 4-5 g/d; volume overload → all CKD; comorbidity coordination; family/caregiver involvement; collaborative care; physician referral pathway; resource-limited settings; health literacy; patient-centered care evidence; technology for patient empowerment |
| **Remaining gaps** | Patient self-efficacy/goal-setting model detail (T3); specific mobile app/social media examples (T3); telemedicine systems for underserved detail (T3) |
| **Review Status** | COMPLETE |
